EC seeks feedback on industrial biotechnology and biomanufacturing

On 13 May 2026, the European Commission launched a call to gather views on the potential for industrial biotechnology and biomanufacturing in the EU. Companies, professionals, experts, academics and citizens are invited to share the main challenges and bottlenecks they encounter and suggestions to address them. The feedback will support the preparation of the Commission's proposal for Biotech Act II, an important element of the Commission work programme 2026, complementing other initiatives in this area, in particular the Bioeconomy Strategy and Biotech Act I. The Bioeconomy Strategy is followed by legislative proposals, with Biotech Act I focusing on health already published, Biotech Act II will follow this year.

The Biotech Act II proposal aims to create an enabling environment for EU industrial biotechnology and biomanufacturing to build a strong business case. This may include generating demand in lead markets and improving predictability for investors to encourage financial commitments within the EU.

Untapped potential of industrial biotechnology and biomanufacturing can support a shift from virgin fossil feedstock the EU is heavily dependent on toward more sustainable inputs, strengthening EU resilience, self-sufficiency, and progress toward climate targets.

The transition to a sustainable circular economy is a strategic EU priority. It can future-proof industry and offer consumers a broader choice of products made from sustainable materials.

The call for evidence is open until 10 June 2026. More information, including details on how to participate, is available on the Commission's ‘Have Your Say' portal.